JP2013231045A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013231045A5 JP2013231045A5 JP2013128011A JP2013128011A JP2013231045A5 JP 2013231045 A5 JP2013231045 A5 JP 2013231045A5 JP 2013128011 A JP2013128011 A JP 2013128011A JP 2013128011 A JP2013128011 A JP 2013128011A JP 2013231045 A5 JP2013231045 A5 JP 2013231045A5
- Authority
- JP
- Japan
- Prior art keywords
- factor
- antibody
- antigen
- binding fragment
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012634 fragment Substances 0.000 claims description 15
- 239000000427 antigen Substances 0.000 claims description 13
- 102000036639 antigens Human genes 0.000 claims description 13
- 108091007433 antigens Proteins 0.000 claims description 13
- 206010018910 Haemolysis Diseases 0.000 claims description 7
- 230000008588 hemolysis Effects 0.000 claims description 7
- 230000037361 pathway Effects 0.000 claims description 7
- 238000000034 method Methods 0.000 claims 12
- 108091007491 NSP3 Papain-like protease domains Proteins 0.000 claims 2
- 238000003556 assay Methods 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 5
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 5
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4843108P | 2008-04-28 | 2008-04-28 | |
| US61/048,431 | 2008-04-28 | ||
| US4868908P | 2008-04-29 | 2008-04-29 | |
| US61/048,689 | 2008-04-29 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011507553A Division JP5636359B2 (ja) | 2008-04-28 | 2009-04-27 | ヒト化抗ｄ因子抗体とその用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013231045A JP2013231045A (ja) | 2013-11-14 |
| JP2013231045A5 true JP2013231045A5 (https=) | 2016-02-25 |
| JP5931008B2 JP5931008B2 (ja) | 2016-06-08 |
Family
ID=40999836
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011507553A Expired - Fee Related JP5636359B2 (ja) | 2008-04-28 | 2009-04-27 | ヒト化抗ｄ因子抗体とその用途 |
| JP2013128011A Expired - Fee Related JP5931008B2 (ja) | 2008-04-28 | 2013-06-18 | ヒト化抗ｄ因子抗体とその用途 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011507553A Expired - Fee Related JP5636359B2 (ja) | 2008-04-28 | 2009-04-27 | ヒト化抗ｄ因子抗体とその用途 |
Country Status (35)
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3299027A1 (en) | 2005-11-04 | 2018-03-28 | Genentech, Inc. | Use of complement pathway inhibitors to treat ocular diseases |
| PL2289909T3 (pl) | 2005-11-30 | 2015-04-30 | Abbvie Inc | Sposób przeszukiwania, proces oczyszczania niedyfundujących oligomerów Abeta, selektywne przeciwciała przeciw niedyfundującym oligomerom Abeta i sposób wytwarzania tych przeciwciał |
| RU2432362C2 (ru) | 2005-11-30 | 2011-10-27 | Эбботт Лэборетриз | Моноклональные антитела и их применения |
| CN106188303A (zh) | 2006-11-02 | 2016-12-07 | 健泰科生物技术公司 | 人源化的抗‑d因子抗体 |
| US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| CR20170001A (es) | 2008-04-28 | 2017-08-10 | Genentech Inc | Anticuerpos anti factor d humanizados |
| US20110165648A1 (en) * | 2009-11-04 | 2011-07-07 | Menno Van Lookeren Campagne | Co-crystal structure of factor D and anti-factor D antibody |
| ES2684475T3 (es) * | 2010-04-15 | 2018-10-03 | Abbvie Inc. | Proteínas que se unen a beta amiloide |
| CN103298833B (zh) | 2010-08-14 | 2015-12-16 | Abbvie公司 | β淀粉样蛋白结合蛋白 |
| EP2670847B1 (en) * | 2011-02-03 | 2016-10-05 | XOMA Technology Ltd. | Methods and materials for enhancing functional protein expression in bacteria |
| KR101966712B1 (ko) | 2011-03-25 | 2019-04-09 | 인텔 코포레이션 | 분할가능한 엔진에 의해 인스턴스화된 가상 코어를 이용한 코드 블록의 실행을 지원하는 메모리 프래그먼트 |
| WO2013077876A1 (en) * | 2011-11-22 | 2013-05-30 | Soft Machines, Inc. | A microprocessor accelerated code optimizer |
| AU2013318047A1 (en) * | 2012-09-19 | 2015-03-12 | Genentech, Inc. | Methods and compositions for preventing norleucine misincorporation into proteins |
| EP2935589A1 (en) | 2012-12-18 | 2015-10-28 | Novartis AG | Compositions and methods that utilize a peptide tag that binds to hyaluronan |
| CA2902026C (en) | 2013-03-13 | 2023-08-29 | Prothena Biosciences Limited | Tau immunotherapy |
| EP2972836B1 (en) | 2013-03-15 | 2022-11-09 | Intel Corporation | A method for emulating a guest centralized flag architecture by using a native distributed flag architecture |
| US10183988B2 (en) * | 2013-06-07 | 2019-01-22 | Duke University | Anti-Complement factor H antibodies |
| WO2015006507A1 (en) | 2013-07-09 | 2015-01-15 | Annexon, Inc. | Methods of treatment for alzheimer's disease and huntington's disease |
| AU2014306867B2 (en) * | 2013-08-12 | 2017-10-26 | Genentech, Inc. | Compositions and method for treating complement-associated conditions |
| WO2015054298A1 (en) * | 2013-10-07 | 2015-04-16 | Massachusetts Eye And Ear Infirmary | Methods of preventing or reducing photoreceptor cell death |
| EP3137503A1 (en) | 2014-05-01 | 2017-03-08 | Genentech, Inc. | Anti-factor d antibody variants and uses thereof |
| EP3160991A2 (en) | 2014-06-25 | 2017-05-03 | Novartis AG | Compositions and methods for long acting proteins |
| WO2015198243A2 (en) | 2014-06-25 | 2015-12-30 | Novartis Ag | Compositions and methods for long acting proteins |
| US9840553B2 (en) | 2014-06-28 | 2017-12-12 | Kodiak Sciences Inc. | Dual PDGF/VEGF antagonists |
| ES2904553T3 (es) * | 2015-10-30 | 2022-04-05 | Hoffmann La Roche | Fragmentos de anticuerpo modificados con bisagra y procedimientos de preparación |
| KR102162324B1 (ko) | 2015-10-30 | 2020-10-07 | 제넨테크, 인크. | 항-HtrA1 항체 및 이의 사용 방법 |
| US10407510B2 (en) | 2015-10-30 | 2019-09-10 | Genentech, Inc. | Anti-factor D antibodies and conjugates |
| US20170137535A1 (en) * | 2015-10-30 | 2017-05-18 | Genentech, Inc. | Anti-factor d antibody formulations |
| HK1257425A1 (zh) | 2015-10-30 | 2019-10-18 | 豪夫迈‧罗氏有限公司 | 测量因子d活性和因子d抑制剂效力的方法 |
| WO2017075252A1 (en) * | 2015-10-30 | 2017-05-04 | Genentech, Inc. | Anti-factor d antibody variant conjugates and uses thereof |
| WO2017091719A1 (en) * | 2015-11-24 | 2017-06-01 | Annexon, Inc. | Anti-complement factor c1q fab fragments and uses thereof |
| KR102799807B1 (ko) | 2015-12-30 | 2025-04-24 | 코디악 사이언시스 인코포레이티드 | 항체 및 이의 접합체 |
| EP3405577B8 (en) * | 2016-01-20 | 2023-02-15 | 396419 B.C. Ltd. | Compositions and methods for inhibiting factor d |
| CN107043422B (zh) * | 2016-01-28 | 2022-01-04 | 成都康弘生物科技有限公司 | 抗补体因子D的人源化Fab和人源化抗体及其用途 |
| EP3452507B1 (en) * | 2016-05-02 | 2022-10-19 | Prothena Biosciences Limited | Tau immunotherapy |
| WO2018136827A1 (en) | 2017-01-20 | 2018-07-26 | Vitrisa Therapeutics, Inc. | Stem-loop compositions and methods for inhibiting factor d |
| EP3580241A4 (en) | 2017-02-10 | 2021-01-06 | The Trustees Of The University Of Pennsylvania | ANTIFACTOR D ANTIBODIES AND USES THEREOF |
| CN106905431B (zh) * | 2017-04-10 | 2020-01-17 | 旭华（上海）生物研发中心有限公司 | 抗人补体d因子的单克隆抗体及其用途 |
| CA3059938A1 (en) | 2017-04-14 | 2018-10-18 | Kodiak Sciences Inc. | Complement factor d antagonist antibodies and conjugates thereof |
| CN110881274B (zh) | 2017-05-02 | 2024-11-15 | 普罗塞纳生物科学有限公司 | 识别tau的抗体 |
| US10865238B1 (en) | 2017-05-05 | 2020-12-15 | Duke University | Complement factor H antibodies |
| GB201800620D0 (en) | 2018-01-15 | 2018-02-28 | Univ Manchester | C3b Binding Polypeptide |
| MX2020009152A (es) | 2018-03-02 | 2020-11-09 | Kodiak Sciences Inc | Anticuerpos de il-6 y constructos de fusion y conjugados de los mismos. |
| US12172106B2 (en) | 2018-08-09 | 2024-12-24 | Regeneron Pharmaceuticals, Inc. | Methods for assessing binding affinity of an antibody variant to the neonatal Fc receptor |
| CA3157509A1 (en) | 2019-10-10 | 2021-04-15 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
| WO2023114763A1 (en) | 2021-12-13 | 2023-06-22 | Annexon, Inc. | Anti-complement factor c1q antibodies with single binding arms and uses thereof |
| WO2025208782A1 (en) * | 2024-04-02 | 2025-10-09 | Linno (Hangzhou) Pharmaceuticals Inc. | Cfd-binding antibody fragments and uses thereof |
Family Cites Families (104)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| US4737456A (en) | 1985-05-09 | 1988-04-12 | Syntex (U.S.A.) Inc. | Reducing interference in ligand-receptor binding assays |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US4946783A (en) | 1987-01-30 | 1990-08-07 | President And Fellows Of Harvard College | Periplasmic protease mutants of Escherichia coli |
| US5010182A (en) | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
| ATE105585T1 (de) | 1987-12-21 | 1994-05-15 | Univ Toledo | Transformation von keimenden pflanzensamen mit hilfe von agrobacterium. |
| US5256642A (en) | 1988-04-01 | 1993-10-26 | The Johns Hopkins University | Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof |
| AU4005289A (en) | 1988-08-25 | 1990-03-01 | Smithkline Beecham Corporation | Recombinant saccharomyces |
| US6048728A (en) | 1988-09-23 | 2000-04-11 | Chiron Corporation | Cell culture medium for enhanced cell growth, culture longevity, and product expression |
| NZ230747A (en) | 1988-09-30 | 1992-05-26 | Bror Morein | Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
| CA2018228C (en) | 1989-06-05 | 1996-02-27 | Nancy L. Parenteau | Cell culture systems and media |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| US5508192A (en) | 1990-11-09 | 1996-04-16 | Board Of Regents, The University Of Texas System | Bacterial host strains for producing proteolytically sensitive polypeptides |
| US5264365A (en) | 1990-11-09 | 1993-11-23 | Board Of Regents, The University Of Texas System | Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides |
| EP1400536A1 (en) * | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| WO1993006217A1 (en) | 1991-09-19 | 1993-04-01 | Genentech, Inc. | EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab')2 ANTIBODIES |
| US5456909A (en) | 1992-08-07 | 1995-10-10 | T Cell Sciences, Inc. | Glycoform fractions of recombinant soluble complement receptor 1 (sCR1) having extended half-lives in vivo |
| WO1994004188A1 (en) | 1992-08-21 | 1994-03-03 | Genentech, Inc. | Method for treating an lfa-1-mediated disorder |
| US5861156A (en) | 1993-01-08 | 1999-01-19 | Creative Biomolecules | Methods of delivering agents to target cells |
| US5856300A (en) | 1994-05-12 | 1999-01-05 | T Cell Sciences, Inc. | Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions |
| US5679546A (en) | 1993-09-24 | 1997-10-21 | Cytomed, Inc. | Chimeric proteins which block complement activation |
| US5627264A (en) | 1994-03-03 | 1997-05-06 | Alexion Pharmaceuticals, Inc. | Chimeric complement inhibitor proteins |
| AU2191795A (en) | 1994-03-23 | 1995-10-09 | Alexion Pharmaceuticals, Inc. | Method for reducing immune and hemostatic dysfunctions during extracorporeal circulation |
| US5534615A (en) | 1994-04-25 | 1996-07-09 | Genentech, Inc. | Cardiac hypertrophy factor and uses therefor |
| US6074642A (en) | 1994-05-02 | 2000-06-13 | Alexion Pharmaceuticals, Inc. | Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis |
| US5679345A (en) | 1994-06-02 | 1997-10-21 | The Johns Hopkins University | Method for preventing complement-dependent rejection of organ or tissue transplants |
| WO2001004311A1 (en) | 1999-07-07 | 2001-01-18 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US5897475A (en) | 1994-10-05 | 1999-04-27 | Antex Biologics, Inc. | Vaccines comprising enhanced antigenic helicobacter spp. |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5639635A (en) | 1994-11-03 | 1997-06-17 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| WO1997038123A1 (en) | 1996-04-05 | 1997-10-16 | Board Of Regents, The University Of Texas System | Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells |
| WO2002000690A2 (en) | 2000-06-23 | 2002-01-03 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| US20050197285A1 (en) | 1997-03-07 | 2005-09-08 | Rosen Craig A. | Human secreted proteins |
| US6472520B2 (en) | 1997-03-21 | 2002-10-29 | The Trustees Of Columbia University In The City Of New York | Rat PEG-3 promoter |
| US6083715A (en) | 1997-06-09 | 2000-07-04 | Board Of Regents, The University Of Texas System | Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells |
| AU756490B2 (en) | 1997-08-26 | 2003-01-16 | Abgenix, Inc. | A process for inhibiting complement activation via the alternative pathway |
| US6410708B1 (en) | 1997-11-21 | 2002-06-25 | Genentech, Inc. | Nucleic acids encoding A-33 related antigen polypeptides |
| US8088386B2 (en) | 1998-03-20 | 2012-01-03 | Genentech, Inc. | Treatment of complement-associated disorders |
| US7282565B2 (en) | 1998-03-20 | 2007-10-16 | Genentech, Inc. | PRO362 polypeptides |
| ES2288649T3 (es) | 1997-11-21 | 2008-01-16 | Genentech, Inc. | Antigenos tipo a-33 y sus utilizaciones farmacologicas. |
| US7192589B2 (en) | 1998-09-16 | 2007-03-20 | Genentech, Inc. | Treatment of inflammatory disorders with STIgMA immunoadhesins |
| US7419663B2 (en) | 1998-03-20 | 2008-09-02 | Genentech, Inc. | Treatment of complement-associated disorders |
| US8007798B2 (en) | 1997-11-21 | 2011-08-30 | Genentech, Inc. | Treatment of complement-associated disorders |
| EP1053245A4 (en) | 1998-02-09 | 2002-04-17 | Human Genome Sciences Inc | 45 HUMAN SECRETED PROTEINS |
| US7112327B2 (en) | 1998-02-20 | 2006-09-26 | Tanox, Inc. | Inhibition of complement activation |
| US6956107B2 (en) * | 1998-02-20 | 2005-10-18 | Tanox, Inc. | Inhibitors of complement activation |
| BR9909220A (pt) | 1998-02-20 | 2000-11-21 | Tanox Inc | Inibidores de ativação de complemento |
| JP3868740B2 (ja) | 1998-03-10 | 2007-01-17 | ジェネンテック・インコーポレーテッド | 新規なポリペプチド及びそれをコードする核酸 |
| AU5587799A (en) | 1998-08-27 | 2000-03-21 | Incyte Pharmaceuticals, Inc. | Protein transport-associated molecules |
| KR100468978B1 (ko) | 1998-12-16 | 2005-02-02 | 제넨테크, 인크. | 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산 |
| JP3993746B2 (ja) | 1998-12-22 | 2007-10-17 | ジェネンテック・インコーポレーテッド | 腫瘍性細胞成長阻害のための組成物及び方法 |
| HU230769B1 (hu) | 1999-01-15 | 2018-03-28 | Genentech Inc. | Módosított effektor-funkciójú polipeptid-változatok |
| CA2362427A1 (en) | 1999-03-08 | 2000-09-14 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| NZ514091A (en) | 1999-03-11 | 2004-01-30 | Rmf Dictagene S | Vascular adhesion molecules and modulation of their function |
| US6642353B1 (en) | 1999-03-17 | 2003-11-04 | Chugai Seiyaku Kabushiki Kaisha | Peptide ligands for the erythropoietin receptor |
| JP2003514541A (ja) | 1999-11-19 | 2003-04-22 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | １８個のヒト分泌タンパク質 |
| EP1672070A3 (en) | 1999-12-01 | 2006-10-04 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US6821775B1 (en) | 2000-02-11 | 2004-11-23 | Genvec, Inc. | Viral vector encoding pigment epithelium-derived factor |
| AU2001249410A1 (en) | 2000-03-23 | 2001-10-03 | Tanox, Inc. | Anti-c2/c2a inhibitors of complement activation |
| AU2001261103B2 (en) | 2000-04-29 | 2007-08-23 | University Of Iowa Research Foundation | Diagnostics and therapeutics for macular degeneration-related disorders |
| CA2416538A1 (en) | 2000-07-20 | 2002-01-31 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| AU2001296594A1 (en) | 2000-10-10 | 2002-04-22 | Tanox, Inc. | Inhibition of complement c5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection |
| MXPA03003144A (es) | 2000-10-13 | 2004-12-06 | Biogen Inc | Anticuerpos humanizados anti-lt-??-r. |
| US20040077575A1 (en) | 2002-01-11 | 2004-04-22 | Giordano Giovan Giacomo | Inhibition of pathological angiogenesis in vivo |
| BRPI0211953B8 (pt) | 2001-08-17 | 2021-05-25 | Genentech Inc | anticorpo monoclonal ou fragmento de ligação a antígeno que se liga a c5 e c5a sem a prevenção da formação de c5b, linhagem celular, composição farmacêutica, bem como método in vitro para inibir a atividade de c5a e método de diagnóstico in vitro |
| TWI323265B (en) * | 2002-08-06 | 2010-04-11 | Glaxo Group Ltd | Antibodies |
| WO2004022594A2 (en) | 2002-09-06 | 2004-03-18 | Cytos Biotechnology Ag | Immune modulatory compounds and methods |
| US7816497B2 (en) | 2002-10-30 | 2010-10-19 | University Of Kentucky | Compositions and methods for inhibiting drusen complement components C3a and C5a for the treatment of age-related macular degeneration |
| RU2232991C1 (ru) | 2003-04-09 | 2004-07-20 | Государственное учреждение "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского" | Способ определения функциональной активности фактора d комплемента человека |
| US7709610B2 (en) * | 2003-05-08 | 2010-05-04 | Facet Biotech Corporation | Therapeutic use of anti-CS1 antibodies |
| WO2005014849A2 (en) | 2003-07-03 | 2005-02-17 | Euro-Celtique, S.A. | Genes associated with responses to neuropathic pain |
| WO2005025509A2 (en) | 2003-09-11 | 2005-03-24 | Board Of Regents, The University Of Texas System | Methods and materials for treating autoimmune diseases and conditions |
| US20050169921A1 (en) * | 2004-02-03 | 2005-08-04 | Leonard Bell | Method of treating hemolytic disease |
| US7127355B2 (en) | 2004-03-05 | 2006-10-24 | Perlegen Sciences, Inc. | Methods for genetic analysis |
| US7794713B2 (en) * | 2004-04-07 | 2010-09-14 | Lpath, Inc. | Compositions and methods for the treatment and prevention of hyperproliferative diseases |
| CN102618644A (zh) | 2004-11-18 | 2012-08-01 | 耶鲁大学 | 治疗眼病的方法和组合物 |
| WO2006071856A2 (en) | 2004-12-23 | 2006-07-06 | Glycofi, Inc. | Immunoglobulins comprising predominantly a man5glcnac2 glycoform |
| EP2357254A1 (en) | 2005-02-14 | 2011-08-17 | University of Iowa Research Foundation | Methods and reagents for treatment and diagnosis of age-related macular degeneration |
| EP2570491A1 (en) | 2005-06-08 | 2013-03-20 | University of Pittsburgh of the Commonwealth System of Higher Education | Susceptibility genes for age-related maculopathy (ARM) on chromosome 10q26 |
| MX351152B (es) | 2005-10-08 | 2017-10-04 | Potentia Pharmaceuticals Inc | Compstatina y analogos de la misma para tratar trastornos oculares. |
| EP3299027A1 (en) | 2005-11-04 | 2018-03-28 | Genentech, Inc. | Use of complement pathway inhibitors to treat ocular diseases |
| US20070190057A1 (en) | 2006-01-23 | 2007-08-16 | Jian Wu | Methods for modulating mannose content of recombinant proteins |
| CN106188303A (zh) | 2006-11-02 | 2016-12-07 | 健泰科生物技术公司 | 人源化的抗‑d因子抗体 |
| US20090111708A1 (en) | 2007-05-11 | 2009-04-30 | Seddon Johanna M | Polynucleotides associated with age-related macular degeneration and methods for evaluating patient risk |
| AR066660A1 (es) | 2007-05-23 | 2009-09-02 | Genentech Inc | Prevencion y tratamiento de condiciones del ojo asociadas con su complemento |
| EP2283163B1 (en) | 2008-04-18 | 2015-07-08 | Tufts Medical Center | Polymorphisms associated with age-related macular degeneration and methods for evaluating patient risk |
| CR20170001A (es) | 2008-04-28 | 2017-08-10 | Genentech Inc | Anticuerpos anti factor d humanizados |
| CN103333952B (zh) | 2008-11-05 | 2015-07-29 | 健泰科生物技术公司 | 年龄相关的黄斑变性中的遗传多态性 |
| US20120115925A1 (en) | 2008-12-23 | 2012-05-10 | Massachusetts Eye And Ear Infirmary | Allelic Variants Associated with Advanced Age-Related Macular Degeneration |
| WO2010085542A2 (en) | 2009-01-23 | 2010-07-29 | Novartis Ag | Biomarkers related to age-related macular degeneration (amd) |
| US20110165648A1 (en) * | 2009-11-04 | 2011-07-07 | Menno Van Lookeren Campagne | Co-crystal structure of factor D and anti-factor D antibody |
| JP5651527B2 (ja) * | 2011-05-02 | 2015-01-14 | 沖電気工業株式会社 | 無線端末装置、無線通信システム、プログラムおよび無線通信方法 |
-
2009
- 2009-03-27 CR CR20170001A patent/CR20170001A/es unknown
- 2009-04-27 EP EP17157837.0A patent/EP3235829B1/en active Active
- 2009-04-27 AR ARP090101490A patent/AR071510A1/es active IP Right Grant
- 2009-04-27 KR KR1020107026550A patent/KR101322027B1/ko not_active Expired - Fee Related
- 2009-04-27 WO PCT/US2009/041785 patent/WO2009134711A1/en not_active Ceased
- 2009-04-27 PT PT97395131T patent/PT2283041E/pt unknown
- 2009-04-27 RS RS20150745A patent/RS54405B1/sr unknown
- 2009-04-27 MY MYPI2010004883A patent/MY162350A/en unknown
- 2009-04-27 CN CN201310681246.5A patent/CN103724433B/zh not_active Expired - Fee Related
- 2009-04-27 PL PL09739513T patent/PL2283041T3/pl unknown
- 2009-04-27 SI SI200931308T patent/SI2283041T1/sl unknown
- 2009-04-27 BR BRPI0907701-4A patent/BRPI0907701A2/pt not_active Application Discontinuation
- 2009-04-27 JP JP2011507553A patent/JP5636359B2/ja not_active Expired - Fee Related
- 2009-04-27 DK DK09739513.1T patent/DK2283041T3/da active
- 2009-04-27 SG SG2013025630A patent/SG189756A1/en unknown
- 2009-04-27 NZ NZ603492A patent/NZ603492A/en not_active IP Right Cessation
- 2009-04-27 PE PE2009000572A patent/PE20091783A1/es active IP Right Grant
- 2009-04-27 AU AU2009241348A patent/AU2009241348C1/en not_active Ceased
- 2009-04-27 CA CA2908470A patent/CA2908470A1/en not_active Abandoned
- 2009-04-27 TW TW103106291A patent/TWI616456B/zh not_active IP Right Cessation
- 2009-04-27 HR HRP20151259TT patent/HRP20151259T1/hr unknown
- 2009-04-27 MX MX2010011342A patent/MX2010011342A/es active IP Right Grant
- 2009-04-27 CA CA2720853A patent/CA2720853C/en not_active Expired - Fee Related
- 2009-04-27 TW TW098113922A patent/TWI558413B/zh not_active IP Right Cessation
- 2009-04-27 SG SG10201608305SA patent/SG10201608305SA/en unknown
- 2009-04-27 CL CL2009001001A patent/CL2009001001A1/es unknown
- 2009-04-27 RU RU2010148423/10A patent/RU2488594C2/ru not_active IP Right Cessation
- 2009-04-27 ES ES09739513.1T patent/ES2552817T3/es active Active
- 2009-04-27 NZ NZ588457A patent/NZ588457A/xx not_active IP Right Cessation
- 2009-04-27 US US12/430,479 patent/US8273352B2/en not_active Expired - Fee Related
- 2009-04-27 MY MYPI2014003450A patent/MY172433A/en unknown
- 2009-04-27 EP EP09739513.1A patent/EP2283041B1/en active Active
- 2009-04-27 TW TW106129777A patent/TW201819418A/zh unknown
- 2009-04-27 NZ NZ621103A patent/NZ621103A/en not_active IP Right Cessation
- 2009-04-27 KR KR1020137017779A patent/KR20130084330A/ko not_active Ceased
- 2009-04-27 EP EP15178110.1A patent/EP3002295A1/en not_active Withdrawn
- 2009-04-27 HU HUE09739513A patent/HUE026349T2/en unknown
- 2009-04-27 CN CN200980123668.2A patent/CN102066419B/zh not_active Expired - Fee Related
- 2009-04-27 PE PE2013002736A patent/PE20140806A1/es active IP Right Grant
-
2010
- 2010-10-07 IL IL208555A patent/IL208555A/en active IP Right Grant
- 2010-10-15 MX MX2018013087A patent/MX2018013087A/es unknown
- 2010-11-11 MA MA33342A patent/MA32300B1/fr unknown
- 2010-11-19 CO CO10145550A patent/CO6331346A2/es active IP Right Grant
- 2010-11-26 CR CR11817A patent/CR11817A/es unknown
- 2010-11-26 EC EC2010010637A patent/ECSP10010637A/es unknown
-
2012
- 2012-05-04 AR ARP120101576A patent/AR086272A2/es unknown
- 2012-08-22 US US13/591,755 patent/US8614306B2/en not_active Expired - Fee Related
-
2013
- 2013-03-06 ZA ZA2013/01709A patent/ZA201301709B/en unknown
- 2013-06-18 JP JP2013128011A patent/JP5931008B2/ja not_active Expired - Fee Related
- 2013-09-20 US US14/033,175 patent/US9676868B2/en not_active Expired - Fee Related
-
2014
- 2014-03-05 US US14/198,021 patent/US20140212433A1/en not_active Abandoned
- 2014-03-07 PH PH12014500519A patent/PH12014500519B1/en unknown
-
2015
- 2015-11-23 US US14/948,911 patent/US20160145349A1/en not_active Abandoned
- 2015-11-26 CY CY20151101079T patent/CY1116982T1/el unknown
-
2017
- 2017-05-18 US US15/598,735 patent/US20180100024A1/en not_active Abandoned
- 2017-06-19 IL IL253014A patent/IL253014A0/en unknown
-
2018
- 2018-02-28 CL CL2018000537A patent/CL2018000537A1/es unknown
- 2018-04-25 HK HK18105422.7A patent/HK1245812A1/en unknown
- 2018-07-27 US US16/048,002 patent/US20190185579A1/en not_active Abandoned
-
2019
- 2019-04-15 IL IL266039A patent/IL266039A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013231045A5 (https=) | ||
| JP2017048240A5 (https=) | ||
| CU20200090A7 (es) | Anticuerpos frente a entpd2 y terapias de combinación | |
| FI2726510T3 (fi) | Kaksoiskohdennus | |
| EA201890302A1 (ru) | Химерные рецепторы антигенов на основе однодоменных антител и способы их применения | |
| PH12016501212A1 (en) | Human anti-il-33 neutralizing monoclonal antibody | |
| JP2017505125A5 (https=) | ||
| CR20170026A (es) | Anticuerpos anti-tau humanizados | |
| ES2776179T3 (es) | Anticuerpos dirigidos contra determinantes de la superficie de S. aureus | |
| PH12015501505B1 (en) | Antibodies that bind to tl1a and their uses | |
| JP2017524725A5 (https=) | ||
| JP2017518366A5 (https=) | ||
| EA201490053A1 (ru) | Антитела, которые связываются с ox40, и их применение | |
| AR105267A1 (es) | Anticuerpos de unión a tau | |
| CY1121158T1 (el) | Αντισωμα ικανο να αναγνωριζει ειδικα υποδοχεα τρανσφερρινης | |
| MX366359B (es) | Anticuerpos humanizados contra la molecula de adhesion celular relacionada al antigeno carcinoembrionico 1 (ceacam1). | |
| JP2021502984A5 (https=) | ||
| CO2017004753A2 (es) | Anticuerpos que se unen a ccr6 | |
| ZA201806397B (en) | Humanized anti clever-1 antibodies and their use | |
| IL286690A (en) | Anti-egfrviii antibodies and antigen-binding fragments thereof | |
| EP3543337A4 (en) | NEW Fab FRAGMENT OF ANTI-HUMAN MUC1 ANTIBODIES | |
| CO2021014153A2 (es) | Anticuerpo monoclonal que se une específicamente a gitr | |
| IL289488A (en) | Monoclonal antibodies that bind egfrviii and their use | |
| EP4043490C0 (en) | Humanized Anti-VEGF Fabricated Antibody Fragment and its Use | |
| JP2018525320A5 (https=) |